Primary |
Depression |
69.8% |
Bipolar Disorder |
4.7% |
Panic Disorder |
4.7% |
Acute And Transient Psychotic Disorder |
2.3% |
Bipolar I Disorder |
2.3% |
Depressive Symptom |
2.3% |
Hypertension |
2.3% |
Intervertebral Disc Protrusion |
2.3% |
Neuralgia |
2.3% |
Post-traumatic Stress Disorder |
2.3% |
Schizophrenia |
2.3% |
Type 1 Diabetes Mellitus |
2.3% |
|
Suicide Attempt |
27.7% |
Hypertensive Crisis |
6.4% |
Somnolence |
6.4% |
Suicidal Ideation |
6.4% |
Visual Acuity Reduced |
6.4% |
Drug Withdrawal Syndrome |
4.3% |
Gamma-glutamyltransferase Increased |
4.3% |
Nausea |
4.3% |
Tachycardia |
4.3% |
Tremor |
4.3% |
Vertigo |
4.3% |
Weight Increased |
4.3% |
Acute Lymphocytic Leukaemia |
2.1% |
Atrioventricular Block |
2.1% |
Blood Chromogranin A Increased |
2.1% |
Bone Marrow Failure |
2.1% |
Breast Cancer |
2.1% |
Cardiac Failure |
2.1% |
Circulatory Collapse |
2.1% |
Delusional Disorder, Unspecified Type |
2.1% |
|
Secondary |
Drug Use For Unknown Indication |
22.0% |
Depression |
19.6% |
Product Used For Unknown Indication |
8.9% |
Anaesthesia |
7.9% |
Hypertension |
5.6% |
Obsessive-compulsive Disorder |
3.7% |
Essential Hypertension |
3.3% |
Prophylaxis Of Neural Tube Defect |
3.3% |
Thyroid Disorder |
3.3% |
Psychotic Disorder |
2.8% |
Schizophrenia |
2.8% |
Schizophrenia, Paranoid Type |
2.8% |
Sleep Disorder |
2.8% |
Post-traumatic Stress Disorder |
2.3% |
Bipolar Disorder |
1.9% |
Coronary Artery Disease |
1.9% |
Hypercholesterolaemia |
1.9% |
Hypothyroidism |
1.9% |
Borderline Personality Disorder |
0.9% |
Anxiety |
0.5% |
|
Suicide Attempt |
16.9% |
Neonatal Respiratory Distress Syndrome |
9.9% |
Syncope |
9.9% |
Vertigo |
8.5% |
Visual Acuity Reduced |
7.0% |
Rhabdomyolysis |
5.6% |
Tachycardia |
5.6% |
Weight Increased |
5.6% |
Vomiting |
4.2% |
Gamma-glutamyltransferase Increased |
2.8% |
Hyperglycaemia |
2.8% |
Liver Function Test Abnormal |
2.8% |
Psychiatric Symptom |
2.8% |
Suicidal Ideation |
2.8% |
Torsade De Pointes |
2.8% |
Vaginal Haemorrhage |
2.8% |
White Blood Cell Count Increased |
2.8% |
Abortion Spontaneous |
1.4% |
Anaemia |
1.4% |
Atrioventricular Block |
1.4% |
|
Concomitant |
Product Used For Unknown Indication |
22.4% |
Depression |
16.2% |
Hypertension |
12.0% |
Drug Use For Unknown Indication |
6.9% |
Gouty Arthritis |
5.4% |
Breast Cancer |
4.2% |
Coronary Artery Disease |
3.9% |
Atrial Fibrillation |
2.7% |
Helicobacter Gastritis |
2.7% |
Renal Failure Chronic |
2.7% |
Schizoaffective Disorder |
2.7% |
Sleep Disorder |
2.7% |
Tachyarrhythmia |
2.7% |
Schizophrenia, Paranoid Type |
2.3% |
Endometriosis |
1.9% |
Gouty Tophus |
1.9% |
Psychotic Disorder |
1.9% |
Schizophrenia |
1.9% |
Localised Infection |
1.5% |
Attention Deficit/hyperactivity Disorder |
1.2% |
|
Drug Interaction |
11.5% |
Suicide Attempt |
9.8% |
Neutropenia |
8.2% |
Pulmonary Embolism |
8.2% |
Tremor |
8.2% |
Leukopenia |
6.6% |
Renin Increased |
6.6% |
Staring |
4.9% |
Dysphoria |
3.3% |
Headache |
3.3% |
Pancytopenia |
3.3% |
Psoriasis |
3.3% |
Rash |
3.3% |
Red Blood Cell Count Decreased |
3.3% |
Renal Failure Acute |
3.3% |
Spinal Osteoarthritis |
3.3% |
Urinary Retention |
3.3% |
Weight Increased |
3.3% |
Acute Respiratory Distress Syndrome |
1.6% |
Atrioventricular Block First Degree |
1.6% |
|
Interacting |
Depression |
47.9% |
Product Used For Unknown Indication |
33.3% |
Hypertension |
12.5% |
Drug Use For Unknown Indication |
6.3% |
|
Gamma-glutamyltransferase Increased |
20.0% |
Urinary Retention |
16.0% |
Hepatic Enzyme Increased |
12.0% |
Drug Interaction |
8.0% |
Hyponatraemia |
8.0% |
Restlessness |
8.0% |
Sinus Tachycardia |
8.0% |
Liver Function Test Abnormal |
4.0% |
Paraesthesia Oral |
4.0% |
Renin Increased |
4.0% |
Status Epilepticus |
4.0% |
Thrombosis |
4.0% |
|